Jason Ryan of Foundation Medicine Joins Magenta’s C-Suite

Xconomy Boston — 

Magenta Therapeutics (NASDAQ: MGTA) has appointed Jason Ryan to serve as chief operating and financial officer, effective Jan. 1. Ryan is joining Cambridge, MA-based Magenta from Foundation Medicine, where he was CFO. Magenta, which is developing treatments for autoimmune diseases, blood cancers, and genetic diseases, completed its IPO in June.